|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 299.26 USD | +2.16% |
|
-5.38% | -1.27% |
| 02-27 | RBC Lifts Price Target on BeOne Medicines to $425 From $417, Keeps Outperform Rating | MT |
| 02-27 | BeOne Medicines Returns to Profit in 2025 on 40% Revenue Jump | MT |
| Capitalization | 32.5B 28.02B 25.3B 24.27B 44.26B 2,987B 46.32B 299B 120B 1,432B 122B 119B 5,122B | P/E ratio 2026 * |
52.9x | P/E ratio 2027 * | 31.8x |
|---|---|---|---|---|---|
| Enterprise value | 28.83B 24.85B 22.44B 21.53B 39.26B 2,649B 41.08B 265B 106B 1,270B 108B 106B 4,544B | EV / Sales 2026 * |
4.53x | EV / Sales 2027 * | 3.84x |
| Free-Float |
96.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BeOne Medicines AG
| 1 day | +2.16% | ||
| 1 week | -5.38% | ||
| Current month | -5.38% | ||
| 1 month | -15.25% | ||
| 3 months | -8.13% | ||
| 6 months | -13.42% | ||
| Current year | -1.27% |
| 1 week | 290 |  | 315 |
| 1 month | 290 | | 372.73 |
| Current year | 290 | | 372.73 |
| 1 year | 196.45 | | 385.22 |
| 3 years | 126.97 | | 385.22 |
| 5 years | 118.18 | | 426.56 |
| 10 years | 24.53 | | 426.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Oyler
CEO | Chief Executive Officer | 57 | 28/10/2010 |
Xiao Bin Wu
PSD | President | 64 | 01/04/2018 |
Aaron Rosenberg
DFI | Director of Finance/CFO | 50 | 22/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
John Oyler
CHM | Chairman | 57 | 27/01/2016 |
Michael Goller
BRD | Director/Board Member | 51 | 01/04/2015 |
Ranjeev Krishana
BRD | Director/Board Member | 52 | 01/10/2014 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.16% | -5.38% | +16.72% | +25.69% | 32.5B | |
| -2.02% | -5.97% | -11.64% | -10.60% | 46.15B | |
| +0.47% | -12.19% | +19.65% | +54.08% | 31.16B | |
| -1.76% | -1.78% | -5.30% | -20.01% | 29.96B | |
| -0.56% | -3.07% | +152.14% | +296.51% | 19.75B | |
| -0.47% | +0.90% | +55.50% | +107.47% | 14.57B | |
| -1.64% | -5.25% | +24.86% | +3.99% | 13.4B | |
| +0.58% | +5.23% | +45.95% | +137.02% | 13.32B | |
| -1.72% | -9.03% | +114.66% | +103.64% | 12.42B | |
| -0.04% | -7.74% | +21,682.18% | +3,408.77% | 11.97B | |
| Average | -0.44% | -2.80% | +2,209.47% | +410.66% | 22.52B | |
| Weighted average by Cap. | -0.39% | -3.40% | +1,182.16% | +234.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.36B 5.48B 4.95B 4.75B 8.66B 584B 9.06B 58.49B 23.43B 280B 23.86B 23.35B 1,002B | 7.38B 6.37B 5.75B 5.51B 10.05B 678B 10.52B 67.93B 27.21B 325B 27.71B 27.12B 1,164B |
| Net income | 647M 558M 504M 483M 881M 59.45B 922M 5.95B 2.38B 28.51B 2.43B 2.38B 102B | 1.05B 909M 821M 788M 1.44B 96.91B 1.5B 9.7B 3.89B 46.48B 3.96B 3.87B 166B |
| Net Debt | -3.67B -3.17B -2.86B -2.74B -5B -337B -5.23B -33.79B -13.54B -162B -13.78B -13.49B -579B | -4.17B -3.59B -3.24B -3.11B -5.67B -383B -5.94B -38.34B -15.36B -184B -15.64B -15.31B -657B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/03/26 | 299.71 $ | +2.31% | 144,690 |
| 05/03/26 | 292.94 $ | -2.03% | 303,051 |
| 04/03/26 | 299.02 $ | +0.67% | 355,806 |
| 03/03/26 | 297.04 $ | -5.51% | 542,464 |
| 02/03/26 | 314.36 $ | -0.83% | 323,396 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ONC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition